Evidence map›Paper›PMID 40653592›Full record

ReviewCNS spectrums2025

Central nervous system stimulants in recreational and medical use.

Seetal Dodd, Laura Ospina-Pinillos, John S Markowitz

Abstract readReview
In one paragraph

Review in CNS spectrums, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Seetal DoddIMPACT-The Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, VIC, Australia.ORCID 0000-0002-7918-4636
Laura Ospina-PinillosDepartment of Psychiatry and Mental Health, Faculty of Medicine, https://ror.org/03etyjw28Pontificia Universidad Javeriana, Bogota, Colombia.ORCID 0000-0002-7929-1511
John S MarkowitzDepartment of Pharmacotherapy and Translational Research, College of Pharmacy, https://ror.org/02y3ad647University of Florida, Gainesville, FL, USA.ORCID 0000-0002-9830-5392

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stimulants that act on the central nervous system have been used since antiquity for ritual and other uses. Organic chemistry techniques, especially those developed in Germany in the late 1800s, resulted in the isolation and structural determination of several important stimulants. Synthetic pathways for amphetamine and related stimulants were developed in the first half of the 19th century, and these new drugs were widely marketed. Awareness of abuse potential emerged soon after but was contested. Stimulants have been used to counteract fatigue and promote wakefulness during military operations, as well as to treat sleep disorders, since the 1930s. Methylphenidate was approved to treat children with behavioral problems in 1962, predating the recognition of attention deficit hyperactivity disorder (ADHD). Stimulant abuse became a political concern in the post-war period, initially with the use of "pep-pills" by long-haul truck drivers and later as drug dealing became common in night clubs, with new laws limiting availability passed in the early 1960s. They have also been used to increase athletic and cognitive performance. Stimulants are still first-line therapies for ADHD and some sleep disorders; however, newer-generation drugs have been developed with better safety profiles and lower abuse potential. Illicit stimulant use continues to be common in many countries.

Indexed as

Central Nervous System StimulantsSubstance-Related DisordersAttention Deficit Disorder with HyperactivityHumansCentral Nervous System Stimulantsamphetamineattention-deficit hyperactivity disorder (ADHD)catecholamine releasing agentscentral nervous systemdrug abuseStimulant

Identifiers

PMID40653592
PMCPMC13064788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.